Subject Line: Israel Providers List
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Rare Cause of Abdominal Pain in Cystic Fibrosis
BMJ Case Reports: first published as 10.1136/bcr-2013-201259 on 12 November 2013. Downloaded from Images in… Transient intussusception: rare cause of abdominal pain in cystic fibrosis Suheil Artul,1,2 Faozi Artoul,3 George Habib,4 Nabil Abboud5 1Department of Radiology, DESCRIPTION Nazareth Hospital, Nazareth, A 26-year-old man with history of cystic fibrosis, Israel 2Faculty Medicine in the presented to the emergency department with a Galilee, Bar-Ilan University, 2-day history of abdominal pain, nausea and vomit- Safed Israel, Maghar, Israel ing. The patient did not have a history of abdom- 3 Department of Nuclear inal surgery. Medicine, Meir Hospital, On presentation the patient was afebrile and Maghar, Israel 4Department of Medicine, normotensive. Abdominal examination revealed Nazareth Hospital, Nazareth, tenderness in the mid-abdomen and no rebound. Israel Laboratory tests showed slight leucocytosis and 5 Department of Surgery, normal level of amylase. Abdominal plain radio- Nazareth Hospital, Nazareth, Israel graph showed gaseous distention of multiple small bowel loops. Contrast CT of the abdomen showed Correspondence to total fatty replacement of the pancreas (figure 1, Dr Suheil Artul, white arrows), dilated small bowel loops up to [email protected] 4.5 cm in diameter (figure 2, red arrows) and a ‘solid mass’ of 6 cm in long axis ‘cobra head sign’ Figure 2 Contrast-enhanced CT of the abdomen showing (figure 2, black arrows) indicating ileo-ileal intus- dilated small bowel loops up to 4.5 cm in diameter (red susceptions, without any sign of bowel wall suffer- arrows), a ‘solid mass’ of6cminlongaxis‘cobra head sign’ ing such as air or oedema of the involved loop. -
ARTICLES Israel's Migration Balance
ARTICLES Israel’s Migration Balance Demography, Politics, and Ideology Ian S. Lustick Abstract: As a state founded on Jewish immigration and the absorp- tion of immigration, what are the ideological and political implications for Israel of a zero or negative migration balance? By closely examining data on immigration and emigration, trends with regard to the migration balance are established. This article pays particular attention to the ways in which Israelis from different political perspectives have portrayed the question of the migration balance and to the relationship between a declining migration balance and the re-emergence of the “demographic problem” as a political, cultural, and psychological reality of enormous resonance for Jewish Israelis. Conclusions are drawn about the relation- ship between Israel’s anxious re-engagement with the demographic problem and its responses to Iran’s nuclear program, the unintended con- sequences of encouraging programs of “flexible aliyah,” and the intense debate over the conversion of non-Jewish non-Arab Israelis. KEYWORDS: aliyah, demographic problem, emigration, immigration, Israel, migration balance, yeridah, Zionism Changing Approaches to Aliyah and Yeridah Aliyah, the migration of Jews to Israel from their previous homes in the diaspora, was the central plank and raison d’être of classical Zionism. Every stream of Zionist ideology has emphasized the return of Jews to what is declared as their once and future homeland. Every Zionist political party; every institution of the Zionist movement; every Israeli government; and most Israeli political parties, from 1948 to the present, have given pride of place to their commitments to aliyah and immigrant absorption. For example, the official list of ten “policy guidelines” of Israel’s 32nd Israel Studies Review, Volume 26, Issue 1, Summer 2011: 33–65 © Association for Israel Studies doi: 10.3167/isr.2011.260108 34 | Ian S. -
The New Neonatal Care Center at Soroka Medical Center
The New Neonatal Care Center at Soroka Medical Center 1 2 The New Neonatal Care Center at Soroka Medical Center The new Neonatal Care Center will serve all newborns in the Negev and provide full protection against missile attacks in accordance with the standards of the Home Front Command of the Israel Defense Forces. Soroka Medical Center: An Overview With 1,100 beds, Soroka Medical Center is among Israel’s largest and most advanced hospitals, and the country’s busiest. Soroka is the only major medical center in the entire Negev, serving a population of more than one million inhabitants, including 400,000 children, in a region that accounts for 60% of the country’s total land area. Soroka serves as the teaching hospital of both the Medical School of Ben-Gurion University, whose Faculty of Health Sciences is located on the hospital campus, and its Medical School for International Health. On par with leading international institutions, Soroka specializes in areas that include, for example, early detection and treatment of breast cancer using minimally invasive procedures; non-invasive removal of malignant tumors; trauma rehabilitation of children and adolescents; pediatric infectious diseases; and much more. Each year, excellent care is provided to more than 750,000 people at outpatient and clinic visits; 235,000 patients visit our Emergency Medicine Department (the busiest in the country); 80,000 inpatients fill our beds; over33 ,000 patients undergo surgery, and more than 17,000 babies are born. Soroka’s neonatal and pediatric departments provide family-centered intensive care with world-class survival rates. Soroka’s Trauma Unit is the largest and busiest in Israel, always on call, 24 hours a day, 365 days a year. -
Download Abstract Book
RESEARCH UPDATE Table of contents 1. Clinical Outcomes Knee Conditions Hip Conditions Lower Back Conditions Ankle Condition 2. Biomechanical Alignment and Perturbation 39 3. Specific Muscle Activation 53 4. Knee Osteoarthritis Functional Severity Classification & Gait Analysis 57 5 Additional Scientific Evidence 63 ¡ Biomechanical aspects of knee osteoarthritis and AposTherapy - Review A. Elbaz (MD), A. Mor (MD), G.Segal AposTherapy Research Group Abstract Over the past few decades, there has been growing evidence on the importance of biomechanical factors in the pathogenesis of knee osteoarthritis (OA). Knee OA is characterized by decreased neuromuscular control, instability of the knee joint and weakness of the knee musculature, all of which lead to abnormal -
Scientific Program
The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2, -
Antibiotic Treatment for Invasive Listeriosis and Patient
Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality. -
Republication, Copying Or Redistribution by Any Means Is
Republication, copying or redistribution by any means is expressly prohibited without the prior written permission of The Economist The Economist April 5th 2008 A special report on Israel 1 The next generation Also in this section Fenced in Short-term safety is not providing long-term security, and sometimes works against it. Page 4 To ght, perchance to die Policing the Palestinians has eroded the soul of Israel’s people’s army. Page 6 Miracles and mirages A strong economy built on weak fundamentals. Page 7 A house of many mansions Israeli Jews are becoming more disparate but also somewhat more tolerant of each other. Page 9 Israel at 60 is as prosperous and secure as it has ever been, but its Hanging on future looks increasingly uncertain, says Gideon Licheld. Can it The settlers are regrouping from their defeat resolve its problems in time? in Gaza. Page 11 HREE years ago, in a slim volume enti- abroad, for Israel to become a fully demo- Ttled Epistle to an Israeli Jewish-Zionist cratic, non-Zionist state and grant some How the other fth lives Leader, Yehezkel Dror, a veteran Israeli form of autonomy to Arab-Israelis. The Arab-Israelis are increasingly treated as the political scientist, set out two contrasting best and brightest have emigrated, leaving enemy within. Page 12 visions of how his country might look in a waning economy. Government coali- the year 2040. tions are fractious and short-lived. The dif- In the rst, it has some 50% more peo- ferent population groups are ghettoised; A systemic problem ple, is home to two-thirds of the world’s wealth gaps yawn. -
The Peres Center for Peace, Tel-Aviv April 12Th, 2019
April 12th, 2019 The Peres Center for Peace, Tel-Aviv BREAST CANCER INNOVATIONS The Israeli Society for Clinical Oncology and Radiation Therapy and Roche are Pleased to Invite You to an Enriching and Educating Meeting with our Distinguished Guest Speaker: Prof. Charles E. Geyer Please Send the Attached Registration Form to A.M Knasim No Later than April 1st 2019 E-mail: [email protected] Tel: 03-6081520 Fax: 03-6081522 Prof. Charles E. Geyer Friday, 12th April 2019 • Professor of Medicine 08:00-09:00 Welcome Reception • Harrigan, Haw, Luck Families Chair in Cancer Research 09:00-09:10 Opening Remarks • Virginia Commonwealth University, Massey Dr. Noa Efrat Ben-Baruch Cancer Center Head, Israeli Breast Cancer Group • Associate Director of Clinical Research Head, Department of Oncology Kaplan Medical Center Charles E. Geyer, Jr. is Professor of Medicine and the Harrigan, Haw, Luck Families Chair in Cancer Research at Virginia Commonwealth University Massey Chairmen: Dr. Georgeta Fried Cancer Center, an NCI-designated Cancer Center. He serves as Associate Director Head Breast Cancer Unit of Clinical Research for the Massey Cancer Center with oversight responsibility Rambam Medical Center for all cancer-related clinical research activities within the Center. Prof. Geyer Dr. Margarita Tokar has devoted most of his academic career on the design and conduct of multi- institutional, phase III clinical trials in breast cancer with a particular focus on Senior Oncologist the development of HER2 targeted therapies. He has served in several leadership Soroka University Medical Center positions for multi-institution research initiatives. These include vice-chair of the 09:10-09:30 Personalized Nanothechnologies in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Committee Management of Breast Cancer from 1999 until 2007, Associate Director of Medical Affairs from 2002 to 2006 and Director of Medical Affairs for NSABP from 2006 to 2011. -
Directory of Development Organizations
EDITION 2007 VOLUME II.A / ASIA AND THE MIDDLE EAST DIRECTORY OF DEVELOPMENT ORGANIZATIONS GUIDE TO INTERNATIONAL ORGANIZATIONS, GOVERNMENTS, PRIVATE SECTOR DEVELOPMENT AGENCIES, CIVIL SOCIETY, UNIVERSITIES, GRANTMAKERS, BANKS, MICROFINANCE INSTITUTIONS AND DEVELOPMENT CONSULTING FIRMS Resource Guide to Development Organizations and the Internet Introduction Welcome to the directory of development organizations 2007, Volume II: Asia and the Middle East The directory of development organizations, listing 51.500 development organizations, has been prepared to facilitate international cooperation and knowledge sharing in development work, both among civil society organizations, research institutions, governments and the private sector. The directory aims to promote interaction and active partnerships among key development organisations in civil society, including NGOs, trade unions, faith-based organizations, indigenous peoples movements, foundations and research centres. In creating opportunities for dialogue with governments and private sector, civil society organizations are helping to amplify the voices of the poorest people in the decisions that affect their lives, improve development effectiveness and sustainability and hold governments and policymakers publicly accountable. In particular, the directory is intended to provide a comprehensive source of reference for development practitioners, researchers, donor employees, and policymakers who are committed to good governance, sustainable development and poverty reduction, through: the -
From Deficits and Dependence to Balanced Budgets and Independence
From Deficits and Dependence to Balanced Budgets and Independence The Arab Local Authorities’ Revenue Sources Michal Belikoff and Safa Agbaria Edited by Shirley Racah Jerusalem – Haifa – Nazareth April 2014 From Deficits and Dependence to Balanced Budgets and Independence The Arab Local Authorities’ Revenue Sources Michal Belikoff and Safa Agbaria Edited by Shirley Racah Jerusalem – Haifa – Nazareth April 2014 From Deficits and Dependence to Balanced Budgets and Independence The Arab Local Authorities’ Revenue Sources Research and writing: Michal Belikoff and Safa Ali Agbaria Editing: Shirley Racah Steering committee: Samah Elkhatib-Ayoub, Ron Gerlitz, Azar Dakwar, Mohammed Khaliliye, Abed Kanaaneh, Jabir Asaqla, Ghaida Rinawie Zoabi, and Shirley Racah Critical review and assistance with research and writing: Ron Gerlitz and Shirley Racah Academic advisor: Dr. Nahum Ben-Elia Co-directors of Sikkuy’s Equality Policy Department: Abed Kanaaneh and Shirley Racah Project director for Injaz: Mohammed Khaliliye Hebrew language editing: Naomi Glick-Ozrad Production: Michal Belikoff English: IBRT Jerusalem Graphic design: Michal Schreiber Printed by: Defus Tira This pamphlet has also been published in Arabic and Hebrew and is available online at www.sikkuy.org.il and http://injaz.org.il Published with the generous assistance of: The European Union This publication has been produced with the assistance of the European Union. Its contents are the sole responsibility of Sikkuy and Injaz and can in no way be taken to reflect the views of the European Union. The Moriah Fund UJA-Federation of New York The Jewish Federations of North America Social Venture Fund for Jewish-Arab Equality and Shared Society The Alan B. -
David Chayen: Innovative Diagnostic Tools and Treatments for Vascular Diseases 6 HEALTHY Livinggolden Age New in Israel
September 2020 HEALTHY LIVINGGolden Age 4 MEIRAV COHEN, Minister of Social Equality & Elderly Citizens: Advocating for seniors DR. DAVID CHAYEN: Innovative diagnostic tools and treatments for vascular diseases 6 HEALTHY LIVINGGolden Age New in Israel TABLE OF CONTENTS AdULT AbSorpTIon prodUcTS! 4 10 20 Meirav Cohen: Introducing Embrace Championing the Livinguard gray hair • Inspire overnight pull-ups, made in the US, in the rights of Face Mask – Erica Pearson a variety of sizes for a relaxed night’s sleep or seniors scientifically proven worry-free extended day use Neria Barr to destroy 99.9% of • Huge 2,100 ml absorption!!! coronaviruses 24 The magic • sizes: s/m, l, xl, xxl 6 touch Innovative 12 Mike Anthony diagnostic tools Nugobars - Great • Egosan extra day/night absorbing underwear, made in Italy and novel taste and good nutrition 28 • The underwear’s anatomical shape allows for treatments for Stalked by vascular Jonathan Gilad better adherence to the body, prevents fluid the fear that dripping and allows for perfect absorption diseases dementia is • Sizes: S, M, L, XL Shosh Rothenberg 16 stalking you Driving safely into Judith Graham starting - 50 SHEKELS ! the golden years 8 The Mayo Clinic Nofei Hasharon: 30 Maintaining Cool and • Egosan absorption diapers – maxi overnight, healthy mind 18 refreshing - made in Italy and body Fight the Illness Summer soups • 4,000 ml absorption! Nadia Barzilay Catherine Marfin Daniel Neman now - bUy 7 - GET 1 FrEEE !! KoLbS GEL SUprEME cUSHIon For wHEELcHAIrS And GEnErAL USE • pressure-reducing visco gel designed to assist in the prevention and healing of pressure ulcers. 260 • High-quality sculpted foam visco. -
Cyclosporin for Severe Ulcerative Colitis
Original Articles Cyclosporin for Severe Ulcerative Colitis Timna Naftali MD1, Ben Novis MD1, Itamar Pomeranz MD1, George Leichtman MD1, Yaakov Maor MD1, Rivka Shapiro MD2, Menachem Moskowitz MD3, Beni Avidan MD4, Yona Avni MD5, Yoram Buja- nover MD6 and Zvi Fireman MD7 1Department of Gastroenterology, Meir Hospital, Kfar Saba, 2Department of Pediatric Gastroenterology, Schneider Childrens Medical Center, Petah Tiqva, 3Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, 4Department of Gastroenterology, Sheba Medical Center, Tel-Hashomer, Departments of 5Gastroenterology and 6Pediatrics, Wolfson Hospital, Holon, and 7Department of Gastroenterology, Hillel Yaffe Hospital, Hadera, Israel Key words: cyclosporin, ulcerative colitis, colectomy, corticosteroids For Editorial see page 607 oids both rectally and intravenously [1]. About 30% of patients with severe ulcerative colitis do not respond to Abstract this treatment and require urgent total colectomy [2]. It was recently shown that cyclosporin is effective in this Background: About one-third of patients with severe group of patients. However, experience is limited and the ulcerative colitis do not respond to conventional therapy numbers of patients reported are relatively small. The aim and require urgent colectomy. It was recently shown that of this study was to review the experience with cyc- cyclosporin is effective in some of these patients. losporin for the treatment of severe ulcerative colitis in Objectives: To review the current experience of six six hospitals in Israel. hospitals in central Israel that used cyclosporin in patients with severe ulcerative colitis. Patients and Methods Methods: The files of all 32 patients treated with cyc- The files of all 32 patients treated with cyclosporin for losporin for corticosteroid-resistant ulcerative colitis were ulcerative colitis in six hospitals in central Israel were reviewed.